Table 7 Hazard ratios (95% CI) for categorical cumulative exposure, and coefficients (95% CI) for continuous cumulative exposure

a. Kidney cancer (N=42)

PCE

1.40 (0.54, 3.58) N=8

1.82 (0.75, 4.42) N=11

1.59 (0.66, 3.86) N=11

.00009 (-0.00048, 0.00065), p=.76

.0813 (-0.0553, 0.2179), p=.24

TVOC

1.42 (0.58, 3.47) N=10

1.44 (0.58, 3.59) N=10

1.54 (0.63, 3.75) N=11

.00001 (-0.00003, 0.00005) p=.59

.0633 (-0.0481, 0.1747) p=.26

b. Hodgkin lymphoma (N=24)

TCE

1.52 (0.42, 5.59) N=4

1.63 (0.43, 6.12) N=4

1.97 (0.55, 7.03) N=5

.00005 (-0.00003, 0.00013) p=.20

.0940 (-0.0650, 0.2530) p=.25

VC

1.20 (0.29, 4.94) N=3

2.07 (0.59, 7.27) N=5

1.99 (0.56, 7.13) N=5

.00056 (-0.00060, 0.00172) p=.34

.1101 (-0.0817, 0.3019) p=.26

Benzene

1.24 (0.30, 5.11) N=3

1.88 (0.54, 6.61) N=5

1.94 (0.54, 6.95) N=5

.00203 (-0.00339, 0.00745) p=.46

.1074 (-0.1088, 0.3236) p=.33

TVOC

0.66 (0.13, 3.39) N=2

1.77 (0.50, 6.25) N=5

2.17 (0.63, 7.50) N=6

.00003 (-0.00003, 0.00009) p=.24

.0752 (-0.0818, 0.2322) p=.35

c. Leukemias (N=66)

TCE

2.00 (1.00, 4.00) N=16

1.54 (0.71, 3.36) N=11

1.81 (0.85, 3.85) N=13

.00002 (-0.00004, 0.00008) p=.46

.0801 (-0.0093, 0.1695) p=.08

Benzene

2.54 (1.27, 5.08) N=17

1.46 (0.66, 3.20) N=11

1.69 (0.77, 3.67) N=12

.00168 (-0.00158, 0.00494) p=.31

.1276 (0.0020, 0.2532) p=.05

TVOC

2.50 (1.24, 5.03) N=19

1.33 (0.56, 3.14) N=9

2.33 (1.08, 5.03) N=15

.00001 (-0.00003, 0.00005) p=.44

.0950 (0.0032, 0.1868) p=.04

d. ALS (N=21)

TCE

0.91 (0.25, 3.23) N=4

0.87 (0.21, 3.57) N=3

1.93 (0.65, 5.79) N=8

.00007 (0.00001, 0.00013) p=.04

.0436 (-0.1083, 0.1955) p=.57

PCE

0.69 (0.13, 3.55) N=2

1.58 (0.45, 5.50) N=5

1.96 (0.64, 6.02) N=8

.00039 (-0.00002, 0.00080) p=.06

.0836 (-0.1060, 0.2732) p=.39

VC

1.22 (0.33, 4.51) N=4

0.91 (0.22, 3.87) N=3

2.21 (0.71, 6.86) N=8

.00110 (0.00020, 0.00200) p=.02

.0724 (-0.1149, 0.2597) p=.45

TVOC

1.27 (0.37, 4.41) N=5

0.89 (0.21, 3.82) N=3

2.11 (0.67, 6.68) N=8

.00005 (0.00001, 0.00009) p=.03

.0702 (-0.0872, 0.2276) p=.38